RxDoctor Payments Data

Tanner Olsen, PA

Physician Assistant · Gilbert, AZNPI 1942840335

Payments from drug & device makers

$2,529in general payments, 2019–2025

Across 63 payments — averaging $40.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Relievant Medsystems, Inc.$285
  • Boston Scientific$283
  • Collegium Pharmaceutical, Inc.$253
  • Medtronic$198
  • Nevro Corp.$143
  • plus $208 from 4 others

What the payments were for

  • Food & beverage$2,529100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,529 in reported general payments places this provider in the 80th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$85,517
Medicare patients
204
Services billed
2,151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen461$17,143
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen637$16,857
Xtampza ErOxycodone Myristate33$10,505
Oxycodone Hcl672$10,107
MovantikNaloxegol Oxalate15$7,730
Buprenorphine28$5,908
Gabapentin340$5,619
Naloxone Hcl93$5,379
Pregabalin154$4,662
Tizanidine Hcl239$3,730
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl18$3,653
Diclofenac Sodium110$2,652
Buprenorphine Hcl27$2,280
Cyclobenzaprine Hcl130$2,265
Morphine Sulfate82$2,256

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$253$10,50533 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Gilbert

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →